EMvision Medical Devices Ltd (ASX: EMV) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
EMvision Medical Devices Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
EMvision Medical Devices Ltd (ASX: EMV)
Latest News

Earnings Results
3 ASX shares soaring on earnings updates

Healthcare Shares
EMvision share price rockets 11% on $5 million pay day

Technology Shares
Here's why the EMvision share price surged 8% on Wednesday

Healthcare Shares
EMvision (ASX:EMV) share price slides 5% following FDA update

Share Gainers
EMvision (ASX:EMV) share price leaps 14% on product update

Healthcare Shares
The EMvision (ASX:EMV) share price jumped today. Here's why

Healthcare Shares
Why is the EMvision (ASX:EMV) share price surging 12% this week?

Share Market News
Why the EMvision (ASX: EMV) share price closed 13% higher today

Share Market News
Why the EMvision (ASX:EMV) share price is going nowhere
Share Market News
Here's why the EMvision (ASX:EMV) share price is up 9% this week

Share Market News
EMvision (ASX:EMV) share price falling despite positive results
EMV ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About EMvision Medical Devices Ltd
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research, development, and commercialization of medical imaging and diagnostic technology. It is seeking to commercialize a potentially low-cost, portable medical imaging device using electromagnetic microwave imaging for stroke diagnosis and monitoring and other medical imaging needs.
EMV Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
01 Dec 2023 | $1.59 | $0.06 | 3.92% | 39,821 | $1.60 | $1.60 | $1.57 |
30 Nov 2023 | $1.53 | $-0.10 | -6.15% | 2,719 | $1.51 | $1.53 | $1.51 |
29 Nov 2023 | $1.63 | $0.02 | 1.25% | 15,355 | $1.60 | $1.66 | $1.60 |
28 Nov 2023 | $1.60 | $0.08 | 5.26% | 35,899 | $1.52 | $1.60 | $1.52 |
27 Nov 2023 | $1.52 | $-0.04 | -2.56% | 108,836 | $1.60 | $1.65 | $1.50 |
24 Nov 2023 | $1.56 | $-0.05 | -3.11% | 28,501 | $1.62 | $1.62 | $1.54 |
23 Nov 2023 | $1.61 | $-0.10 | -5.87% | 56,943 | $1.62 | $1.65 | $1.61 |
22 Nov 2023 | $1.71 | $0.00 | 0.00% | 37,519 | $1.70 | $1.71 | $1.64 |
21 Nov 2023 | $1.71 | $0.01 | 0.59% | 19,442 | $1.69 | $1.72 | $1.68 |
20 Nov 2023 | $1.70 | $0.07 | 4.29% | 94,802 | $1.63 | $1.75 | $1.63 |
17 Nov 2023 | $1.63 | $0.02 | 1.24% | 15,475 | $1.60 | $1.63 | $1.60 |
16 Nov 2023 | $1.61 | $0.01 | 0.63% | 30,938 | $1.60 | $1.61 | $1.60 |
15 Nov 2023 | $1.60 | $0.06 | 3.88% | 61,633 | $1.55 | $1.63 | $1.55 |
14 Nov 2023 | $1.55 | $-0.10 | -6.10% | 7,259 | $1.61 | $1.61 | $1.55 |
13 Nov 2023 | $1.64 | $0.00 | 0.00% | 7,980 | $1.63 | $1.64 | $1.63 |
10 Nov 2023 | $1.64 | $0.05 | 3.16% | 19,496 | $1.57 | $1.64 | $1.53 |
09 Nov 2023 | $1.58 | $0.03 | 1.94% | 69,829 | $1.57 | $1.66 | $1.57 |
08 Nov 2023 | $1.55 | $0.03 | 1.97% | 34,408 | $1.54 | $1.60 | $1.53 |
07 Nov 2023 | $1.53 | $-0.05 | -3.17% | 7,182 | $1.52 | $1.53 | $1.52 |
06 Nov 2023 | $1.58 | $0.03 | 1.95% | 13,135 | $1.58 | $1.58 | $1.56 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
29 Sep 2023 | Phillip Dubois | Expiry | 500,000 | $850,000 |
Options expired.
|
05 May 2023 | Ronald (Ron) Weinberger | Cancelled | 776,398 | $1,234,472 |
Cancellation of securities.
|
05 May 2023 | Ronald (Ron) Weinberger | Exercise | 223,602 | $1,250,000 |
Exercise of options. VWAP
|
05 May 2023 | Ronald (Ron) Weinberger | Buy | 223,602 | $1,250,000 |
Exercise of options. VWAP
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr Phillip James Dubois | Non-Executive Director | Sep 2020 |
Dr Dubois is a neuroradiologist and nuclear imaging specialist, former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association.
|
Dr Ronald (Ron) Peter Weinberger | Non-Executive Director | May 2020 |
Dr Weinberger has more than 20 years' experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018,Dr Weinberger was responsible for the direction of Nanosonics' technology development and commercialisation strategy. He is co-inventor of several of Nanosonics' key technology patents.
|
Mr Anthony (Tony) Keane | Non-Executive Director | Jun 2018 |
Mr Keane is an experienced business and finance executive and holds a number of independent non-executive director and advisory board roles.Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking.Mr Keane is currently an Independent Non-Executive Director and Chairman of National Storage Holdings Ltd, the holding company established for National Storage REIT.He is Chair of Risk Committee.
|
Mr Geoffrey (Geoff) Richard Pocock | Non-Executive Director | Mar 2018 |
Mr Geoff Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets.Mr Pocock previously spent several years as a research scientist in the biopharmaceutical industry in Australia and the United Kingdom.
|
Mr John Keep | Non-Executive ChairmanNon-Executive Director | Mar 2018 |
Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the restructuring and revitalization of the radiology company Queensland Diagnostic Imaging, Queensland's leading private radiology and diagnostic imaging group and at Lemarne Healthcare, a company specialising in the detection and treatment of skin cancer.He is Member of Risk Committee.
|
Mr Scott Kirkland | Co-founderExecutive DirectorChief Executive OfficerManaging Director | Jul 2017 |
Mr Scott Kirkland has held senior sales positions,including Head of Client Sales at Quantcast, a US based technology company.Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.Mr Kirkland is a member of the Australian Institute of Company Directors.
|
Ms Emma Waldon | Chief Financial OfficerCompany Secretary |
-
|
|
Emma Waldon | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Mr Scott Philip Kirkland | 3,861,987 | 4.96% |
Ryan Michael Laws | 3,250,000 | 4.17% |
Dr Ronald Peter Weinberger | 2,108,727 | 2.71% |
Mr Paul Raymond Brown & Mrs Angelique Susan Brown<Brown Family A/C> | 1,358,250 | 1.74% |
Jm Starcevich Investments Pty Ltd | 1,230,000 | 1.58% |
Uniquest Pty Limited | 1,200,000 | 1.54% |
Busso Holdings Pty Ltd <Bew A/C> | 1,160,000 | 1.49% |
Glensburg Pty Ltd <Tyto Corp Pension Fund A/C> | 1,112,000 | 1.43% |
Walsh Prestige Pty Ltd <Walsh Family A/C> | 1,050,000 | 1.35% |
Dr Stuart Crozier | 1,044,937 | 1.34% |
Mr Martin Kolev | 1,000,000 | 1.28% |
Neweconomy Com Au Nominees Pty Limited <900 Account> | 986,267 | 1.27% |
Mr Vincent Michael O'Sullivan <O'Sullivan A/C> | 956,000 | 1.23% |
J P Morgan Nominees Australia Pty Limited | 903,028 | 1.16% |
Citicorp Nominees Pty Limited | 882,214 | 1.13% |
Wakil Family Group Pty Ltd <Ron Ton Fashions P/L Rp A/C> | 860,095 | 1.10% |
Oofy Prosser Pty Ltd <Drones Family A/C> | 855,000 | 1.10% |
Hillridge Pty Ltd | 842,425 | 1.08% |
Truebell Capital Pty Ltd <Truebell Investment Fund> | 840,000 | 1.08% |
Kong Pak Lim | 805,500 | 1.03% |